Why some people with APOE4 develop Alzheimer's while others stay healthy
Official title: Study Susceptibility and Resistance to ApoE4 in Alzheimer's Disease
Funded at J. David Gladstone Institutes · NIH-11297482 · Data updated 2026-11-12
This work looks at how the APOE4 gene changes brain activity and biology in ways that raise Alzheimer's risk and why some people with APOE4 remain symptom-free.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | J. David Gladstone Institutes NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | July 1, 2022 |
| Project end | June 30, 2027 |
| Funding year | 2025 |
| Award (this year) | $861,422 |
| NIH project number | 4R01AG076647-02 |
| Project ID | NIH-11297482 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates would be people who carry one or two copies of the APOE ε4 allele, especially older adults or those with family history or early memory concerns.
✕Less likely to help
People who do not carry APOE4 or whose cognitive problems are caused by non-Alzheimer conditions are less likely to benefit directly from this project.
What this research studies
From my perspective as someone concerned about Alzheimer's, the team compares animals engineered to carry the human APOE4 gene with those carrying APOE3 to find brain and molecular differences tied to memory loss. They focus on memory-related brain rhythms called sharp wave ripples and slow gamma activity, and link those signals to changes in amyloid handling and other cell processes. The researchers also study why a subset of APOE4 carriers stay free of dementia despite their genetic risk, aiming to identify protective mechanisms. Findings could point to specific molecular targets or brain processes to guide new prevention or treatment ideas.
Why it matters
Potential benefit: If successful, this work could identify drug targets or brain-based strategies to prevent or delay Alzheimer's in people who carry APOE4.
How similar studies have gone: Past clinical trials targeting amyloid have largely failed, while APOE4-focused approaches have shown promising results in animal studies but remain unproven in humans.
Where this research is happening
-
J. David Gladstone Institutes
San Francisco, United States Active
Researchers
- Principal investigator: Huang, Yadong — J. David Gladstone Institutes
- Study coordinator: Huang, Yadong
Related research
Other NIH-funded projects on the same topics.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
-
Telomerase in Alzheimer’s Disease: how aging biology could influence memory and brain health
Researchers are exploring a new brain-aging mechanism linked to telomerase, with potential to slow or modify Alzheimer’s disease in people and improve cognitive function.
-
Biomarkers of Alzheimer’s Disease: Sensory, Motor, and Cognitive Clues
Researchers are testing simple sensory and movement tasks to find early signs of Alzheimer’s disease so they can diagnose and treat people sooner.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.